The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALM.L Share News (ALM)

  • There is currently no data for ALM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EXTRA: Allied Minds Annual Loss Widens As It Invests In New Businesses

Mon, 25th Apr 2016 10:18

LONDON (Alliance News) - Allied Minds PLC on Monday reported a widened pretax loss in what it called a "successful" 2015, as it increased investment in creating four new businesses and developing its existing enterprises towards commercialisation.

Allied Minds funds and develops start-up companies in the science and technology space.

Shares in Allied Minds were down 5.6% at 379.90 pence Monday morning, the worst performer in the FTSE 250.

The company reported a pretax loss of USD98.0 million for 2015, widened from USD57.7 million in 2014, mostly as a result of higher selling, general and administrative expenses, and a big step up in research and development costs. Revenue fell to USD3.3 million from USD7.7 million, which Allied Minds said was mostly because of a revenue shortfall at food safety company RF Biocidics, caused by a delayed regulatory approval.

Allied Minds said its group subsidiary ownership adjusted value, a key metric for the company, rose to USD535.8 million as at the end of 2015 from USD488.0 million at the end of 2014. It attributed this rise to significant increases in value of some of its subsidiaries including Precision Biopsy and Federated Wireless, which offset decreases in value of RF Biocidics and CryoXtract, and the closing of SiEnergy Systems.

Allied Minds ceased operations at SiEnergy in 2016 after determining that the thin-film solid-oxide fuel-cell technology that the company was developing would not meet key milestones within a reasonable timeframe and budget, compounded by a weaker market for clean energy alternatives due to the low cost of traditional energy sources.

The company said a total of USD102.8 million was invested into new and existing portfolio companies in 2015, including USD63.6 million from two fundraisings led by the company to further accelerate the development of drug discovery company SciFluor Life Sciences and biotechnology firm Precision Biopsy.

Allied Minds formed four new businesses during the year, it said, including HawkEye 360, which is seeking to build and launch a constellation of small satellites, and BridgeSat, which is looking to develop an optical connectivity system to increase the speed, security and efficiency of data from Low Earth Orbit satellites and high-altitude unmanned aerial vehicles.

As part of its efforts to develop its new and existing companies in 2015 Allied Minds increased its total workforce to 359 in 2015 from 234, it said, predominantly engineering and technical development professionals.

"We are happy to report a successful 2015 in which the group continued to make important strides in advancing its subsidiaries towards commercialisation. We invested in existing subsidiaries to accelerate their development, strengthened industry partnerships and also established new strategic relationships, and recruited highly talented individuals to the company," said Chief Executive Officer Chris Silva in a statement.

"We are confident that we will continue to execute on our strategy to drive early-stage technology towards profitable commercial success," Silva added.

By Hana Stewart-Smith; hanassmith@alliancenews.com; @HanaSSAllNews

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
25 Apr 2016 11:00

LONDON MARKET MIDDAY: Resource Stocks Drag FTSE As Brent Rally Stalls

Read more
25 Apr 2016 09:38

WINNERS & LOSERS SUMMARY: St Ives Dives After Profit Warning

Read more
25 Apr 2016 07:36

LONDON MARKET OPEN: Mixed Trade As Miners And Drillers Drag FTSE 100

Read more
25 Apr 2016 07:19

Allied Minds losses widen as group ramps up invesment

(ShareCast News) - Science and technology development company Allied Minds reported a wider loss in 2015 in its annual report on Monday, which it blamed on an increase in its investment in research and development and the creation of four new businesses during the year. The FTSE 250 firm posted a ne

Read more
25 Apr 2016 06:25

TOP NEWS: Allied Minds Loss Widens As It Invests In New Businesses

Read more
18 Apr 2016 15:05

Earnings, Trading Statements Calendar - Week Ahead

Read more
16 Mar 2016 08:36

LONDON MARKET OPEN: Commodity Stocks Take Back Losses But Hikma Falls

Read more
16 Mar 2016 08:08

Allied Minds forms cancer drug arm with NYU School of Medicine

(ShareCast News) - Allied Minds has launched a new subsidiary to develop potential cancer drugs from compounds developed by the New York University School of Medicine. Allied's joint venture with pharma group Bristol-Myers Squibb, Allied-Bristol Life Sciences, has set up the subsidiary, called ißeCa

Read more
16 Mar 2016 07:36

Allied Minds Joint Venture Signs Deal With New York University

Read more
9 Feb 2016 14:47

FTSE 250 movers: Redrow falls despite rise in profits

(ShareCast News) - The FTSE 250 continued to slide on Tuesday, with the second tier market down 140.79 points (0.91%) to 15,357.20 by mid-afternoon. Redrow was near the top of the fallers list despite posting a rise in first half pre-tax profit as revenue and completions grew. In the six months to

Read more
9 Feb 2016 10:42

WINNERS & LOSERS SUMMARY: Bond Disclosure Sends Legal & General Higher

Read more
9 Feb 2016 09:08

UPDATE: Allied Minds Hit By Revenue Drop From RF Biocidics Shortfall

Read more
9 Feb 2016 07:59

Allied Minds Eyes Commercialisation Opportunities In 2016

Read more
9 Feb 2016 07:32

Allied Minds marks 2015 as year of investment

(ShareCast News) - Allied Minds laid out 2015 as a year of investment, rather than cashflow, as it updated the market on Tuesday of its trading in the 12 months to 31 December 2015. The company had net cash and investments - including cash in the form of fixed income securities - of $194.8m (£135.37

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.